OPC Pharmaceutical JSC
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, external use, digestion, pain relief-anti-inflammatory, endocrine, and other d… Read more
OPC Pharmaceutical JSC (OPC) - Net Assets
Latest net assets as of : ₫- VND
Based on the latest financial reports, OPC Pharmaceutical JSC (OPC) has net assets worth ₫- VND as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫-) and total liabilities (₫-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OPC Pharmaceutical JSC - Net Assets Trend (None–None)
This chart illustrates how OPC Pharmaceutical JSC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OPC Pharmaceutical JSC (None–None)
The table below shows the annual net assets of OPC Pharmaceutical JSC from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OPC Pharmaceutical JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OPC Pharmaceutical JSC Competitors by Market Cap
The table below lists competitors of OPC Pharmaceutical JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Trident Resources Corp.
F:6BP0
|
$48.06 Million |
|
Frontier Digital Ventures Ltd
AU:FDV
|
$48.09 Million |
|
Catana Group S.A.
LSE:0OGG
|
$48.11 Million |
|
Viva Leisure Ltd
AU:VVA
|
$48.11 Million |
|
Yunsa Yunlu Sanayi ve Ticaret AS
IS:YUNSA
|
$48.06 Million |
|
SolarBank Corporation Common Stock
OTCQX:SUUN
|
$48.03 Million |
|
Seoho Electric Co.Ltd
KQ:065710
|
$48.02 Million |
|
Shindaeyang Pa
KO:016590
|
$48.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OPC Pharmaceutical JSC's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OPC Pharmaceutical JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OPC Pharmaceutical JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OPC Pharmaceutical JSC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,979,636,361,615
- Average return on equity (ROE) among peers: 16.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OPC Pharmaceutical JSC (OPC) | ₫- | N/A | N/A | $48.06 Million |
| Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) | $1.66 Trillion | 16.57% | 0.36x | $183.29 Million |
| DHG Pharmaceutical JSC (DHG) | $3.57 Trillion | 20.74% | 0.25x | $29.78 Million |
| DOMESCO Medical Import Export JSC (DMC) | $1.25 Trillion | 18.58% | 0.22x | $21.40K |
| Imexpharm Corp (IMP) | $1.73 Trillion | 12.12% | 0.21x | $119.65 Million |
| Traphaco JSC (TRA) | $1.69 Trillion | 14.81% | 0.39x | $27.57 Million |